Nicotinic receptor abnormalities of Alzheimer’s disease: therapeutic implications
- 1 February 2001
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 49 (3), 200-210
- https://doi.org/10.1016/s0006-3223(00)01125-2
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Cholinesterase Inhibitors for the Treatment of Alzheimer??s Disease in the ElderlyDrugs & Aging, 2000
- Worldwide Prevalence and Incidence of DementiaDrugs & Aging, 1999
- Cholinesterase Inhibitors in the Treatment of Alzheimer??s DiseaseDrug Safety, 1998
- Estrogen Replacement Therapy for the Prevention and Treatment of Alzheimer??s DiseaseCNS Drugs, 1997
- In Vivo Imaging of Human Cerebral AcetylcholinesteraseJournal of Neurochemistry, 1996
- CNS Nicotinic ReceptorsCNS Drugs, 1994
- Molecular cloning of human neuronal nicotinic receptor α3-subunitNeuroscience Letters, 1990
- Quantitative autoradiography of nicotinic receptors in large cryosections of human brain hemispheresNeuroscience Letters, 1989
- Distribution of nicotinic receptors in human thalamus as visualized by3H- nicotine and3H-acetylcholine receptor autoradiographyJournal of Neural Transmission, 1988
- Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brainsNeuroscience Letters, 1986